经导管主动脉瓣置换术最佳器械选择的考量:综述
该综述指出,主动脉瓣狭窄是发达国家最常见的获得性瓣膜病,多项大规模随机临床试验已确立经导管主动脉瓣置换术(TAVR)作为外科主动脉瓣置换的安全有效替代方案。目前美国仅有3种TAVR器械上市,另有多种瓣膜处于临床试验阶段,因工程特征差异各器械有特定优势与局限。由于缺乏大规模头对头比较且器械迭代迅速,现有证据不足以宣称某种器械优于其他。
要点
- TAVR已成为严重症状性主动脉瓣狭窄从低危到禁忌风险患者的外科换瓣替代方案。
- 美国现有3种上市TAVR器械,各因设计差异有独特优势和局限。
- 缺乏大规模头对头比较,无法宣称某种器械类型优于其他。
核心结论
- 现有证据不足以宣称一种TAVR器械类型优于另一种。
- 某些患者相关和解剖相关因素可能略微 favoring 一种或几种特定设计。
研究设计与样本
- 综述,旨在概述已上市或处于临床研究中的各种TAVR器械的设计特征和临床结局。
主要发现
- 美国目前仅有3种TAVR器械上市,另有其他瓣膜类型正在美国进行临床试验。
- 各TAVR器械类型因工程特征的根本差异而有特定优势和局限。
- 缺乏大规模头对头比较,且新器械迭代快速发展。
临床怎么用
- 鉴于各TAVR器械独特的设计特征,某些患者相关和解剖相关因素可能使特定设计略有优势。
局限性
- 缺乏大规模头对头比较各种TAVR器械的研究。
- 新器械迭代快速发展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Aortic valve stenosis (AS) is the most common manifestation of acquired valvular heart disease in developed countries. Several large-scale randomized clinical trials investigating the entire spectrum of patients with severe symptomatic AS from low to prohibitive risk have established transcatheter aortic valve replacement (TAVR) as a safe and effective alternative to surgical aortic valve replacement. OBSERVATIONS: There are currently only 3 types of TAVR devices commercially available in the US, but several other valve types are undergoing clinical trials in the US. Because of fundamental differences in engineering features, each TAVR device type has specific strengths and limitations. This review aims to provide an overview of design features and clinical outcomes of various TAVR devices that are either commercially available or undergoing clinical investigation. CONCLUSIONS AND RELEVANCE: Given the lack of large-scale head-to-head comparisons of various TAVR devices and the rapid development of new device iterations, there is insufficient evidence to claim superiority of one device type over another. Nonetheless, as each TAVR device has unique design characteristics, certain patient-related and anatomy-related factors may slightly favor one or several particular designs.
引用
- Claessen BE, Tang GHL, Kini AS, et al. Considerations for Optimal Device Selection in Transcatheter Aortic Valve Replacement: A Review. JAMA Cardiol. 2021. PMID: 32902569. doi:10.1001/jamacardio.2020.3682
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。